Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 706

Results For "IT"

10376 News Found

BioPhy launches AI platform to accelerate the drug development market
Digitisation | November 14, 2023

BioPhy launches AI platform to accelerate the drug development market

The company has raised US$4.5 million in funding for its AI operating system


Bayer and Recursion focus research collaboration on Oncology
Digitisation | November 14, 2023

Bayer and Recursion focus research collaboration on Oncology

Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients


Biocon Biologics receives MHRA, UK Approval for Biosimilar Aflibercept ‘Yesafili’
News | November 14, 2023

Biocon Biologics receives MHRA, UK Approval for Biosimilar Aflibercept ‘Yesafili’

Yesafili, received marketing authorization approval from the European Commission for the European Union


Narayana Hrudayalaya Q2 FY PAT up at Rs. 226.58 Cr
News | November 14, 2023

Narayana Hrudayalaya Q2 FY PAT up at Rs. 226.58 Cr

Narayana Hrudayalaya has reported total income of Rs. 1323.64 crores during the period ended September 30, 2023


Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr
News | November 13, 2023

Granules India Q2 FY24 PAT drops 30% at Rs. 102 Cr

Sales in the US region grew well, partially offset by the decline in the LATAM and European regions


Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
News | November 13, 2023

Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr

he company posted total income during Q2 FY24 at Rs. 12.86 crore


Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
News | November 13, 2023

Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr

European operations' revenue grew 58.4% to Rs 599.7 crore


Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr
News | November 13, 2023

Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr

US business grew by +12.8% YoY


SMS Pharmaceuticals reports robust Q2FY24 operational performance
News | November 10, 2023

SMS Pharmaceuticals reports robust Q2FY24 operational performance

Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore


Intermountain Health files complain against Dr. Reddy’s and others
News | November 10, 2023

Intermountain Health files complain against Dr. Reddy’s and others

Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation